ITPRIPL1 and neoplasm: However, in other tumors, there was no significant difference observed (P > 0.05) (Figure 1E).In MESO, we observed that the mRNA expression levels of ITPRIPL1 gradually increased from stage I to stage IV, suggesting its potential role in tumor progression.